[Federal Register Volume 74, Number 124 (Tuesday, June 30, 2009)]
[Notices]
[Pages 31312-31313]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-15445]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated April 1, 2009, and published in the Federal 
Register on April 9, 2009, (74 FR 16234), Lipomed, Inc., One Broadway, 
Cambridge, Massachusetts 02142, made application by renewal to the Drug 
Enforcement Administration (DEA) to be registered as an importer of the 
basic classes of controlled substances listed in schedules I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235)............................  I
Methcathinone (1237)........................  I
N-Ethylamphetamine (1475)...................  I
Fenethylline (1503).........................  I
Methaqualone (2565).........................  I
Gamma Hydroxybutyric Acid (2010)............  I
Lysergic acid diethylamide (7315)...........  I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine
(7348)......................................  I
Marihuana (7360)............................  I
Tetrahydrocannabinols (7370)................  I
Mescaline (7381)............................  I
3,4,5-Trimethoxyamphetamine (7390)..........  I
4-Bromo-2,5-dimethoxyamphetamine (7391).....  I

[[Page 31313]]

 
4-Bromo-2,5-dimethoxyphenethylamine (7392)..  I
4-Methyl-2,5-dimethoxyamphetamine (7395)....  I
2,5-Dimethoxyamphetamine (7396).............  I
2,5-Dimethoxy-4-ethylamphetamine (7399).....  I
3,4-Methylenedioxyamphetamine (7400)........  I
3,4-Methylenedioxy-N-ethylamphetamine (7404)  I
3,4-Methylenedioxymethamphetamine (7405)....  I
4-Methoxyamphetamine (7411).................  I
Dimethyltryptamine (7435)...................  I
Psilocybin (7437)...........................  I
Psilocyn (7438).............................  I
N-Benzylpiperazine (7493)...................  I
Acetyldihydrocodeine (9051).................  I
Dihydromorphine (9145)......................  I
Heroin (9200)...............................  I
Normorphine (9313)..........................  I
Pholcodine (9314)...........................  I
Tilidine (9750).............................  I
3-Methylfentanyl (9813).....................  I
Amphetamine (1100)..........................  II
Methamphetamine (1105)......................  II
Methylphenidate (1724)......................  II
Amobarbital (2125)..........................  II
Pentobarbital (2270)........................  II
Secobarbital (2315).........................  II
Phencyclidine (7471)........................  II
Phenylacetone (8501)........................  II
Cocaine (9041)..............................  II
Codeine (9050)..............................  II
Dihydrocodeine (9120).......................  II
Oxycodone (9143)............................  II
Hydromorphone (9150)........................  II
Benzoylecgonine (9180)......................  II
Ethylmorphine (9190)........................  II
Hydrocodone (9193)..........................  II
Levorphanol (9220)..........................  II
Meperidine (9230)...........................  II
Methadone (9250)............................  II
Dextropropoxyphene, bulk....................
(non-dosage forms) (9273)...................  II
Morphine (9300).............................  II
Thebaine (9333).............................  II
Oxymorphone (9652)..........................  II
Alfentanil (9737)...........................  II
Sufentanil (9740)...........................  II
Fentanyl (9801).............................  II
------------------------------------------------------------------------

    The company plans to import analytical reference standards for 
distribution to its customers for research and analytical purposes.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of Lipomed, Inc. to import the basic classes of controlled 
substances is consistent with the public interest and with United 
States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971, at this time. DEA has investigated 
Lipomed, Inc. to ensure that the company's registration is consistent 
with the public interest. The investigation has included inspection and 
testing of the company's physical security systems, verification of the 
company's compliance with State and local laws, and a review of the 
company's background and history. Therefore, pursuant to 21 U.S.C. 
952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above 
named company is granted registration as an importer of the basic 
classes of controlled substances listed.

    Dated: June 23, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E9-15445 Filed 6-29-09; 8:45 am]
BILLING CODE 4410-09-P